The labeled starting dose is 2.5 mg weekly for at least four weeks
We want to identify really useful peptides that can be leveraged and advanced as treatment for human diseases for which there is no solution at the moment. One potential prospect is MOTs-C, which Cohen discovered and has studied in Phase 1A and Phase 1B trials
It appears to work through multiple mechanisms, including enhanced angiogenesis (formation of new blood vessels), upregulation of growth hormone receptors, and modulation of nitric oxide pathways
IV infusions such as Glutathione provide immense increases in cellular health through increasing immune function, decreasing reactive oxygen species, and enhancing cellular remodeling in the neuronal axons and motor end-plates
Findings from research models should not be interpreted as evidence of safety or effectiveness in humans or animals
Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis